Please log in to view this page
Username
Password
Objectives: Primary: To develop a highly predictive algorithm that identifies TB patients who will be cured by treatment...
A5314 is a phase II randomized, double-blind, placebo-controlled 36-week trial that will examine the safety and efficacy of...
The purpose of this study is to determine whether one or two four-month regimens of tuberculosis treatment are as effective as a...
Study Objective: Compare longitudinal HIV-1 antibody responses among HIV-1 infected participants that either did or did not...
Many factors contribute to the development of aging-related conditions, including gastrointestinal (GI) diseases, such as...
